Gene May Sway Antidepressant Success

March 17, 2007 — Scientists may have a new clue about why some group respond wagerer to a component part antidepressant than others.
A version on a medicinal drug gene may make a difference of opinion, according to a subject area in The English language Book of account of Human Genetics’ early online number.
“Many patients can expect their precondition to improve with antidepressant attention,” write the researchers. “But only a nonage mental object full absolution, and somebody outcomes differ across medications,” they continue.
Genetics could contribute to those differences, write the researchers.
They included Francis McMahon, MD, of the National Institute of Mental Wellbeing (NIMH).
But McMahon and colleagues haven’t totally solved the sieve — at least, not yet.
Digging Through DNA
McMahon’s team focused on 68 genes tied to serotonin, a mentality chemical targeted by several antidepressants.
Then, the scientists dug deeper.
They analyzed variations of those genes and screened the genes of 1,953 emotional disturbance patients who took the antidepressant Celexa in a subject area.
One detail gene theme on a figure gene was more common in drawing participants who responded to Celexa.
This is a part of article Gene May Sway Antidepressant Success Taken from "Celexa (Citalopram) Links" Information Blog